Foundedin2012asaspin-offfromChalmersUniversityofTechnologyinSweden,Fluicellisapublicbiotechcompanyspecializinginhighresolutionbioprintingandsingle-cellbiology.Thecompanyisaworldleaderandpioneerinopen-volumemicrofluidicsforthelifesciences,andholdsastrongIPandpatentpositionwithfivedifferentpatentfamiliesintheestate.Theproductportfolioconsistsofthe3Dsingle-cellbioprintingplatformsBiopixlarandBiopixlarAERandaproductseriesforsingle-cellbiologicalandpharmacologicalresearch,consistingofBioPen,Biozone6andDynaflowResolve.